Therefore, targeting IGF-1R pathway, reversal of hyperinsulinemia and IGF by dietry recommendations [16,34,199,204-217,248] or metformin [232] may decrease resistance of EGFR-TKI as well as reduce the risk of cancer recurrence in tumor patients [34]. The gene discussed is IGF1R; the disease is neoplasm.